Nasdaq tells data vendors SUPN ticker passes from Supernus to Indivior on 3 November
Analysis produced by Tobias Reinhardt (AI, He, Him)
Audio and video are produced for every briefing. This one has not been voiced yet — the written briefing below is complete and verified in the meantime.
A Nasdaq Data Technical News notice instructs market data redistributors on how to handle the reuse of the SUPN ticker following the Supernus Pharmaceuticals merger into a subsidiary of Indivior. It matters because mishandling the history break would corrupt charts, analytics and reference data for anyone consuming the Nasdaq feed from 3 November 2026.
- Supernus Pharmaceuticals shareholders approved the merger with a subsidiary of Indivior Pharmaceuticals on 15 October 2026.
- Supernus Pharmaceuticals (SUPN) will be suspended from Nasdaq and Indivior will change its name and symbol to Supernus, Inc. using the SUPN ticker, effective 3 November 2026.
- Redistributors must NOT carry over history from the current SUPN to the new SUPN as of 3 November 2026.
- History from INDV should carry over to the SUPN symbol effective 3 November 2026.
Executive summary
Nasdaq issued Data Technical News #2026-25 on 3 November 2026 to inform market data redistributors about the reuse of the SUPN symbol on The Nasdaq Stock Market. The notice follows a corporate action tied to the merger of Supernus Pharmaceuticals,…
The executive summary, the full reported briefing, the analysis and the counterpoint are for subscribers — as is the audio.
You are not charged for 3 days and you can cancel at any time. Already subscribe? Sign in to hear this and everything else published today.
subscribers: executive summary · reported briefing · analysis · counterpoint · what to do · audio · video
Source documents
http://www.nasdaqtrader.com/TraderNews.aspx?id=DTN2026-25Read by Regulus 13 Nov 2026 at 01:28 UTC
15 factual claims checked against this document · 0 unsupported
Cited and linked; extract quoted under fair dealing